ZTEK NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

ZEN Graphene Solutions Ltd · Healthcare · Medical Instruments & Supplies

Open interactive chart View report data
Latest close 0.68 USD
27.9% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is 14.4% above the Trend Line and sits at 35.9% of its 52-week range. The latest completed week returned 27.9%, after a 50.8% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is expensive relative to peers. The latest news-sentiment score is 60/100. Near-term considerations: volume confirmation is below normal; earnings are due in 12d.

Setup score 39 out of 100
Latest Close 0.68 USD 31 Jul 2026
1W Return 27.9% latest completed week
4W Return 50.8% short-term follow-through
12W Return -9.9% quarterly tape
Trend Breadth 0.0% 0 of 52 weeks active
Volume Ratio 0.8x vs 13-week average
What is working
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 35.47% based on similar historical setup states.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 27.9% Latest completed week; four-week move 50.8%. Indicator stack 0/91 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 35.47% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 60/100 14 relevant articles in the latest sentiment read. Event risk 12d Next report is scheduled for 13 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 14.4% above the Trend Line and sits at 35.9% of its 52-week range. The latest completed week returned 27.9%, after a 50.8% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0612-week average 0.16

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure7/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.06Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 50.8% over four weeks, -9.9% over 12 weeks, and -17.4% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W27.9%
4W50.8%
12W-9.9%
26W-0.8%
52W-17.4%
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.28Latest activity-pressure read.
Pressure change453.5%Four-week change in activity pressure.
Leadership-8.66Latest relative-leadership reading.
RS change80.7%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 82% Model confidence 78%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength1/100Blend of value, momentum, and quality. Underlying universe rank 100; rank 1 is best.
Value15/100Relative valuation strength. Underlying universe rank 86; rank 1 is best.
Quality2/100Profitability and accounting quality. Underlying universe rank 99; rank 1 is best.
Momentum7/100Medium-term price momentum. Underlying universe rank 94; rank 1 is best.
Growth10/100Revenue and earnings growth. Underlying universe rank 91; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
405.3x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-6.9%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-2522.4%
Gross profit retained from each unit of revenue.
Operating margin
-6146.2%
Operating profit retained from revenue.
Free-cash-flow margin
-2824.5%
Free cash flow generated from revenue.
Return on invested capital
-73.3%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-81.0%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
1/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-4.7%
Net share repurchases relative to market value.
Shareholder yield
-4.7%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.1x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment60/100

Weighted news tone is neutral across 14 relevant articles.

6 positive · 7 neutral · 1 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings12dNext report is scheduled for 13 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-45.2%Distance below the 52-week high.
13-week volatility17.8%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher8 of 2618 weeks finished lower.
Best week+48.4%Week of 8 May.
Worst week-12.8%Week of 5 Jun.
Latest week+27.9%Week of 31 Jul.

Shape of recent returns

Strong gains7
Modest gains1
Flat weeks0
Modest losses5
Sharp losses13
Recent vol17.8%13-week weekly-return volatility.
Base vol12.3%52-week weekly-return volatility.
Up/down split16/35Count of positive and negative weeks in the 52-week window.
Average skew14.7% / -6.3%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape31/100

Trend, activity pressure, participation, and risk combine to a 31/100 tape read.

 Indicator analysis22/100

Latest 12-week confirmation: trend 0/12, activity pressure 7/12, relative leadership 0/12.

Activity pressure 0.06; No reversal markers Next-Week ExpectancyNegative 35.47%

Next-week expectancy is negative with a 35.47% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors5/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 82; Small Cap Core rank 90 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Sentiment60/100

Weighted news tone is neutral across 14 relevant articles.

Zentek Ltd. (NASDAQ: ZTEK) taps IMPAQ for North American IR push Insiders50/100

No recent insider transaction evidence is stored.

 Earnings12d

Next report is scheduled for 13 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20260.68 USD27.9%0.59 USD0.98 USD0.28-8.66761.6KOff
24 Jul 20260.53 USD13.1%0.59 USD0.98 USD-0.03-28.84773.7KOff
17 Jul 20260.47 USD-1.3%0.60 USD0.99 USD-0.00-38.97451.3KOff
10 Jul 20260.48 USD5.7%0.61 USD1.00 USD-0.06-41.591.3MOff
3 Jul 20260.45 USD-7.9%0.62 USD1.00 USD-0.08-44.95497.7KOff
26 Jun 20260.49 USD18.6%0.63 USD1.01 USD0.04-41.063.0MOff
19 Jun 20260.41 USD-9.6%0.63 USD1.02 USD0.10-53.62447.5KOff
12 Jun 20260.46 USD-11.8%0.64 USD1.03 USD0.41-48.91887.7KOff
5 Jun 20260.52 USD-12.8%0.66 USD1.03 USD0.69-42.61574.9KOff
29 May 20260.59 USD-8.2%0.67 USD1.04 USD0.88-39.09645.0KOff
22 May 20260.65 USD-6.2%0.67 USD1.05 USD0.43-33.78580.0KOff
15 May 20260.69 USD-8.6%0.68 USD1.05 USD-0.09-30.602.0MOff
8 May 20260.75 USD48.4%0.68 USD1.06 USD-0.67-26.42812.8KOff
1 May 20260.51 USD8.2%0.68 USD1.06 USD-1.09-49.20644.8KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.